Enhanced expression of human cytochrome P450 1A2 by co-expression with human molecular chaperone Hsp70
- 2 November 2004
- journal article
- Published by Elsevier in Toxicology Letters
- Vol. 153 (2), 267-272
- https://doi.org/10.1016/j.toxlet.2004.05.002
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Development of Bacterial Expression System with High Yield of CYP3A7, a Human Fetus- Specific Form of Cytochrome P450Biochemical and Biophysical Research Communications, 2000
- High Catalytic Activity of Human Cytochrome P450 Co-expressed with Human NADPH-Cytochrome P450 Reductase in Escherichia coliBiochemical Pharmacology, 1998
- Role of the Alanine at Position 363 of Cytochrome P450 2B2 in Influencing the NADPH- and Hydroperoxide-Supported ActivitiesArchives of Biochemistry and Biophysics, 1998
- Expression of drug-metabolizing enzymesCurrent Opinion in Biotechnology, 1997
- Molecular chaperones: Clasping the prizeCurrent Biology, 1996
- Human Cytochrome P450 EnzymesPublished by Springer Nature ,1995
- Expression of Modified Human Cytochrome P450 3A4 in Escherichia coli and Purification and Reconstitution of the EnzymeArchives of Biochemistry and Biophysics, 1993
- Polymorphisms for aromatic amine metabolism in humans: relevance for human carcinogenesis.Environmental Health Perspectives, 1992
- Human cytochrome P-450PA (P-450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines.Proceedings of the National Academy of Sciences, 1989
- Differential effects of phenobarbitone and 3-methylcholanthrene induction on the hepatic microsomal metabolism and cytochrome P-450-binding of phenoxazone and a homologous series of its n-alkyl ethers (alkoxyresorufins)Chemico-Biological Interactions, 1983